Entries by دکتر امین اظهری

Insomnia identified as a new risk factor for type 2 diabetes

A new ‘global atlas’ study published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) is the first to identify insomnia as a risk factor associated with increased risk of developing type 2 diabetes (T2D). The study identifies 34 risk factors that are thought to increase (19) or decrease risk […]

,

New approach against Parkinson’s disease through stem cell

The Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, experimented on patient-based cell cultures in the laboratory. The new combination of active substances they identified will have to undergo clinical trials before they can be used to treat patients. The research team published its results today in the prestigious scientific journal Science […]

Fatter legs linked to reduced risk of high blood pressure

Adults with a higher percentage of fat tissue in their legs were less likely than those with a lower percentage to have high blood pressure. Research findings held true even after adjusting for age, sex, race and ethnicity, education, smoking, alcohol use, cholesterol levels and waist fat, although to a lesser degree. Researchers speculate that […]

,

Impact of ACE-i and ARBs for patients with COVID-19

Low blood pressure, or hypotension, in COVID-19 patients with a history of hypertension appears to be a risk factor for kidney damage and death. Reducing hypertension medications if and when COVID-19 patients become hypotensive could prevent acute kidney injury and death, according to a new study. COVID-19 patients previously taking the blood pressure-lowering drugs angiotensin-converting […]

, ,

Stronger bones thanks to heat and microbiota

Osteoporosis, a bone disease linked to ageing, is characterised by a loss of bone density, micro-architectural deterioration of the bones and an increased risk of fractures. With one third of postmenopausal women affected, it is a major public health problem. Through epidemiological analyses, laboratory experiments and state-of-the-art metagenomic and metabolomics tools, a research team has […]

,

Mediterranean diet and risk of rheumatoid arthritis

The Mediterranean diet (MD) has been reported to be associated with significant reduction of non‐communicable diseases. They aimed to assess the relationship between adherence to the MD and the risk of rheumatoid arthritis, especially in high‐risk individuals. Their results suggest that adherence to the MD could reduce the high risk of RA among ever‐smoking women. […]

,

Substance use disorders linked to COVID-19 susceptibility

NIH research finds higher risk and worse outcomes for those with addiction. A National Institutes of Health-funded study found that people with substance use disorders (SUDs) are more susceptible to COVID-19 and its complications. The research, published today in Molecular Psychiatry. Release date: 14 September 2020 Source: NIH/National Institute on Drug Abuse

,

Levodopa may improve vision in patients with macular degeneration

The widely used and well-tolerated drug commonly used to treat Parkinson’s disease may help significantly reduce the need for more costly, more invasive treatments, report investigators in The American Journal of Medicine. Investigators have determined that treating patients with an advanced form of age-related macular degeneration (AMD) with levodopa, a safe and readily available drug […]

A pain reliever that alters perceptions of risk

People who took acetaminophen rated activities like “bungee jumping off a tall bridge” and “speaking your mind about an unpopular issue in a meeting at work” as less risky than people who took a placebo, researchers found. Use of the drug also led people to take more risks in an experiment where they could earn […]

,

Obesity may alter immune system response to COVID-19

Obesity may cause a hyperactive immune system response to COVID-19 infection that makes it difficult to fight off the virus, according to a new manuscript published in the Endocrine Society’s journal, Endocrinology. Release date: 3 September 2020 Source: The Endocrine Society